Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
5
×
covid-19
5
×
life sciences
national blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
cancer immunotherapy
cystic fibrosis
gilead sciences
novartis
What
bio
roundup
acquisitions
buy
ceo
daniel
days
debut
gilead
ipo
o’day
sciences
way
abbvie’s
ahead
alliance
announced
biggest
biofourmis
biotech
bristol
bucks
build
calls
cancer
celebrate
chance
changing
collabs
color
company
company’s
corner
covid
crispr
day
deal
developing
drug
dyne’s
Language
unset
Current search:
covid-19
×
photo
×
" boston blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More